New Insight to Overcome Tumor Resistance: An Overview from Cellular to Clinical Therapies

Disease relapse caused by drug resistance still represents a major clinical hurdle in cancer treatments. Tumor cells may take advantage of different intracellular and genetic systems attenuating the drug effects. Resistant cells or minimal residual disease (MRD) cells have strong clinical relevance,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitola, Giulia, Falvo, Paolo, Bertolini, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621237/
https://www.ncbi.nlm.nih.gov/pubmed/34833007
http://dx.doi.org/10.3390/life11111131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621237/
https://www.ncbi.nlm.nih.gov/pubmed/34833007
http://dx.doi.org/10.3390/life11111131

Ejemplares similares